Kiadis Pharma Granted U.S. Patent for its Blood Cancer Treatment ATIR™

News   Jan 21, 2013

 
Kiadis Pharma Granted U.S. Patent for its Blood Cancer Treatment ATIR™
 
 
 
FURTHER INFORMATION
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE